Sulfated polysaccharide from Gracilaria caudata reduces hypernociception and inflammatory response during arthritis in rodents

Int J Biol Macromol. 2020 Oct 15:161:1061-1069. doi: 10.1016/j.ijbiomac.2020.06.060. Epub 2020 Jun 10.

Abstract

Polysaccharide from marine alga Gracilaria caudata has potential health benefits, such as anti-inflammatory, gastroprotective and antidiarrheal effects. Here, we investigated the effect of a sulfated polysaccharide from G. caudata (SP-GC) on hypernociception and inflammatory response in arthritis models. The animals received SP-GC (3, 10 or 30 mg/kg) 1 h before tibio-tarsal injection of zymosan. Hypernociception, histopathology, edema, vascular permeability, myeloperoxidase (MPO) activity, cell influx, interleukin (IL)-1β and nitric oxide (NO) levels were evaluated in acute phase. In another protocol, animals received SP-GC (30 mg/kg) 2 h post-complete Freund's adjuvant (CFA). Hypernociception, edema and arthritis index were determined in acute, sub-chronic and chronic phases. Rota-rod test measured the motor performance. SP-GC significantly reduced, in a dose-dependent manner, the zymosan-induced hypernociception with maximal effect at 30 mg/kg. The microscopic inflammation, joint edema, MPO activity, cell influx, IL-1β and NO levels were also reduced by SP-GC. In the CFA-induced arthritis, SP-GC inhibits the hypernociception, edema and arthritic index in acute, sub-chronic and chronic phases. SP-GC did not alter the motor performance of animals. In conclusion, SP-GC exerts protective effect in models of arthritis due to the modulation of cell influx, IL-1β and NO levels, culminating in the reduction of hypernociception and edema.

Keywords: Arthritis; Cell migration; Gracilaria caudata; Hypernociception; Inflammation.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / chemistry*
  • Anti-Inflammatory Agents / pharmacology*
  • Arthritis, Experimental / drug therapy
  • Arthritis, Experimental / etiology
  • Arthritis, Experimental / pathology
  • Biomarkers
  • Capillary Permeability / drug effects
  • Disease Models, Animal
  • Edema / drug therapy
  • Edema / etiology
  • Freund's Adjuvant
  • Gracilaria / chemistry*
  • Immunohistochemistry
  • Male
  • Mice
  • Polysaccharides / chemistry*
  • Polysaccharides / pharmacology*
  • Rodentia
  • Sulfates / chemistry*
  • Zymosan / adverse effects

Substances

  • Anti-Inflammatory Agents
  • Biomarkers
  • Polysaccharides
  • Sulfates
  • Freund's Adjuvant
  • Zymosan